Established markets can rely on peak sales multiple. But new markets for non-approved drugs are generally rNPV. Details of Pharma approach on page 72. Also our mate DrC is a Torreya veteran so this approach is likely to be second nature.
https://torreya.com/publications/pharmaceutical-valuation-in-licensing-dec2013-torreya.pdf
If valuation gaps arise the only way to bridge the gap is earn out milestones and royalty agreements. So it comes down to the partner of negotiation, anything can be on the table.
General Comments / Chat, page-7450
-
- There are more pages in this discussion • 4,217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.78 |
Change
-0.005(0.28%) |
Mkt cap ! $303.3M |
Open | High | Low | Value | Volume |
$1.80 | $1.84 | $1.78 | $133.8K | 73.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 15072 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.87 | 1793 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 15072 | 1.780 |
1 | 1690 | 1.775 |
1 | 11200 | 1.770 |
1 | 2200 | 1.760 |
1 | 569 | 1.755 |
Price($) | Vol. | No. |
---|---|---|
1.870 | 1793 | 1 |
1.880 | 2351 | 1 |
1.890 | 1000 | 1 |
1.895 | 7800 | 1 |
1.950 | 30264 | 5 |
Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online